# APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3

> **NCT00138034** · PHASE4 · COMPLETED · sponsor: **Heartcenter, University Medical Center St. Radboud** · enrollment: 49 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **PROCEDURE:** Percutaneous coronary intervention (PCI)

## Key facts

- **NCT ID:** NCT00138034
- **Lead sponsor:** Heartcenter, University Medical Center St. Radboud
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2010-01
- **Final completion:** 2010-02
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2012-04-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00138034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00138034, "APRICOT-3: Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis -3". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00138034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*